ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

GTHX G1 Therapeutics Inc

3.99
0.13 (3.37%)
After Hours
Last Updated: 16:30:00
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
G1 Therapeutics Inc GTHX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.13 3.37% 3.99 16:30:00
Open Price Low Price High Price Close Price Prev Close
3.85 3.84 4.045 3.99 3.86
more quote information »

Recent News

Date Time Source Heading
4/17/202409:00GLOBEG1 Therapeutics to Release First Quarter 2024 Financial..
4/04/202410:30GLOBEG1 Therapeutics to Participate in the 23rd Annual Needham..
4/01/202416:20GLOBEG1 Therapeutics Announces Inducement Grants Under Nasdaq..
3/01/202416:20GLOBEG1 Therapeutics Announces Inducement Grants Under Nasdaq..
2/28/202406:35EDGAR2Form 8-K - Current report
2/28/202406:30GLOBEG1 Therapeutics Provides Fourth Quarter and Full Year 2023..
2/27/202408:30GLOBEG1 Therapeutics to Participate in the TD Cowen 44th Annual..
2/15/202408:30GLOBEG1 Therapeutics to Release Fourth Quarter and Full Year 2023..
2/13/202418:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/12/202416:42EDGAR2Form 144 - Report of proposed sale of securities
2/12/202416:19EDGAR2Form 8-K - Current report
2/12/202416:05GLOBEG1 Therapeutics to Continue Pivotal Phase 3 Trial of..
1/09/202416:19EDGAR2Form 144 - Report of proposed sale of securities
1/08/202406:45GLOBEG1 Therapeutics Provides Corporate Update at the 42nd Annual..
1/08/202406:30EDGAR2Form 8-K - Current report
1/08/202406:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/08/202406:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/08/202406:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/08/202406:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/08/202406:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/08/202406:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/03/202409:00GLOBEG1 Therapeutics to Participate in the 42nd Annual J.P...
1/02/202419:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/02/202416:51GLOBEG1 Therapeutics Announces Inducement Grants Under Nasdaq..
12/13/202316:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202316:40EDGAR2Form 144 - Report of proposed sale of securities
12/11/202318:43EDGAR2Form 144 - Report of proposed sale of securities
12/05/202309:26GLOBEG1 Therapeutics Presents New Post Hoc Analyses Indicating..
12/01/202316:27GLOBEG1 Therapeutics Announces Inducement Grants Under Nasdaq..
11/29/202320:37GLOBEG1 Therapeutics Announces Upcoming Presentation at the 2023..
11/01/202316:37EDGAR2Form S-8 - Securities to be offered to employees in employee..
11/01/202316:02EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/01/202306:46EDGAR2Form 8-K - Current report
11/01/202306:30GLOBEG1 Therapeutics Provides Third Quarter 2023 Financial..
10/27/202307:00GLOBEReal World Data Indicate That Trilaciclib Reduces..
10/18/202308:00GLOBEG1 Therapeutics’ COSELA® (trilaciclib) Recommended in..
10/18/202307:30GLOBEG1 Therapeutics to Release Third Quarter 2023 Financial..
10/16/202309:00GLOBEG1 Therapeutics Announces Upcoming Presentations at the 2023..
9/21/202316:15EDGAR2Form 8-K - Current report
9/18/202307:00GLOBEBlack Diamond Therapeutics Announces CEO Transition
9/05/202311:00GLOBEG1 Therapeutics to Participate in the H.C. Wainwright 25th..
9/01/202316:15GLOBEG1 Therapeutics Announces Inducement Grants Under Nasdaq..
8/10/202316:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/08/202319:28EDGAR2Form 144 - Report of proposed sale of securities
8/02/202316:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/02/202306:50EDGAR2Form 8-K - Current report
8/02/202306:30GLOBEG1 Therapeutics Provides Second Quarter 2023 Financial..
7/31/202314:30GLOBEG1 Therapeutics to Participate in Two August Investor..
7/31/202308:30GLOBENew Publication Highlights Real World Impact of Trilaciclib..
7/26/202309:00GLOBEG1 Therapeutics to Release Second Quarter 2023 Financial..

Your Recent History

Delayed Upgrade Clock